Knockdown of peroxisome proliferator-activated receptor-[beta] induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells

The role of peroxisome proliferator-activated receptor-beta/delta (PPAR-beta/delta) in the pathogenesis of colon cancer remains highly controversial. This study specifically silenced the PPAR-beta expression in three colon cancer cell lines with different metastatic potentials. Although PPAR-beta kn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2010-01, Vol.29 (4), p.516
Hauptverfasser: Yang, L, Olsson, B, Pfeifer, D, Jönsson, J -i, Zhou, Z -g, Jiang, X, Fredriksson, B -a, Zhang, H, Sun, X -f
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 516
container_title Oncogene
container_volume 29
creator Yang, L
Olsson, B
Pfeifer, D
Jönsson, J -i
Zhou, Z -g
Jiang, X
Fredriksson, B -a
Zhang, H
Sun, X -f
description The role of peroxisome proliferator-activated receptor-beta/delta (PPAR-beta/delta) in the pathogenesis of colon cancer remains highly controversial. This study specifically silenced the PPAR-beta expression in three colon cancer cell lines with different metastatic potentials. Although PPAR-beta knockdown resulted in more malignant morphological changes, bigger colony sizes and lower carcinoembryonic antigen (CEA) secretion, and enhanced the cell-fibronectin adhesion, cell invasion and migration were unaffected. These effects were stronger in poorly metastatic cell lines compared with highly metastatic ones. Simultaneously, PPAR-beta knockdown decreased the mRNAs encoding adipocyte differentiation-related protein and liver fatty acid binding protein, and increased the mRNA of ILK, whereas the mRNAs encoding integrin-beta1 and angiopoietin-like 4 were unchanged. Using immunohistochemistry, we determined that the intensity of PPAR-beta expression was stronger in rectal cancers with better differentiation than in those with poor differentiation, and was stronger in early-stage tumors than in advanced ones. Together, these findings consistently indicate that PPAR-beta may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer, having a role as an inhibitor in the carcinogenesis and progression of colorectal cancer. Interestingly, PPAR-beta seems to have a more important role in poorly metastatic cells than in highly metastatic ones. [PUBLICATION ABSTRACT]
doi_str_mv 10.1038/onc.2009.370
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_227349447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1949137291</sourcerecordid><originalsourceid>FETCH-proquest_journals_2273494473</originalsourceid><addsrcrecordid>eNqNjk1OxDAMhSMEEuVnxwEi9i1u2lKyRiAktuwQGmUSV5Mh2CVJgaNwXFLEAVjZ8vv83hPiooWmhe7misk2CkA33QgHomr78boeBt0figr0ALVWnToWJyntAWDUoCrx_UhsXx1_kuRJzhj5yyd-QzlHDn7CaDLH2tjsP0xGJyNanNfT8xazeZGe3GIxyYApSeen8oGUvcmeSRpyEmlnaCUshlBPfhuZsNgV1e0wrVgJthzKYlcy_pLpTBxNJiQ8_5un4vL-7un2oS7F3hdMebPnJVKRNkqNXa_7fuz-Bf0AHX1g9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227349447</pqid></control><display><type>article</type><title>Knockdown of peroxisome proliferator-activated receptor-[beta] induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells</title><source>Nature</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>Yang, L ; Olsson, B ; Pfeifer, D ; Jönsson, J -i ; Zhou, Z -g ; Jiang, X ; Fredriksson, B -a ; Zhang, H ; Sun, X -f</creator><creatorcontrib>Yang, L ; Olsson, B ; Pfeifer, D ; Jönsson, J -i ; Zhou, Z -g ; Jiang, X ; Fredriksson, B -a ; Zhang, H ; Sun, X -f</creatorcontrib><description>The role of peroxisome proliferator-activated receptor-beta/delta (PPAR-beta/delta) in the pathogenesis of colon cancer remains highly controversial. This study specifically silenced the PPAR-beta expression in three colon cancer cell lines with different metastatic potentials. Although PPAR-beta knockdown resulted in more malignant morphological changes, bigger colony sizes and lower carcinoembryonic antigen (CEA) secretion, and enhanced the cell-fibronectin adhesion, cell invasion and migration were unaffected. These effects were stronger in poorly metastatic cell lines compared with highly metastatic ones. Simultaneously, PPAR-beta knockdown decreased the mRNAs encoding adipocyte differentiation-related protein and liver fatty acid binding protein, and increased the mRNA of ILK, whereas the mRNAs encoding integrin-beta1 and angiopoietin-like 4 were unchanged. Using immunohistochemistry, we determined that the intensity of PPAR-beta expression was stronger in rectal cancers with better differentiation than in those with poor differentiation, and was stronger in early-stage tumors than in advanced ones. Together, these findings consistently indicate that PPAR-beta may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer, having a role as an inhibitor in the carcinogenesis and progression of colorectal cancer. Interestingly, PPAR-beta seems to have a more important role in poorly metastatic cells than in highly metastatic ones. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/onc.2009.370</identifier><identifier>CODEN: ONCNES</identifier><language>eng</language><publisher>New York: Nature Publishing Group</publisher><subject>Cell adhesion &amp; migration ; Cellular biology ; Colorectal cancer ; Fatty acids ; Gene expression</subject><ispartof>Oncogene, 2010-01, Vol.29 (4), p.516</ispartof><rights>Copyright Nature Publishing Group Jan 28, 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Yang, L</creatorcontrib><creatorcontrib>Olsson, B</creatorcontrib><creatorcontrib>Pfeifer, D</creatorcontrib><creatorcontrib>Jönsson, J -i</creatorcontrib><creatorcontrib>Zhou, Z -g</creatorcontrib><creatorcontrib>Jiang, X</creatorcontrib><creatorcontrib>Fredriksson, B -a</creatorcontrib><creatorcontrib>Zhang, H</creatorcontrib><creatorcontrib>Sun, X -f</creatorcontrib><title>Knockdown of peroxisome proliferator-activated receptor-[beta] induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells</title><title>Oncogene</title><description>The role of peroxisome proliferator-activated receptor-beta/delta (PPAR-beta/delta) in the pathogenesis of colon cancer remains highly controversial. This study specifically silenced the PPAR-beta expression in three colon cancer cell lines with different metastatic potentials. Although PPAR-beta knockdown resulted in more malignant morphological changes, bigger colony sizes and lower carcinoembryonic antigen (CEA) secretion, and enhanced the cell-fibronectin adhesion, cell invasion and migration were unaffected. These effects were stronger in poorly metastatic cell lines compared with highly metastatic ones. Simultaneously, PPAR-beta knockdown decreased the mRNAs encoding adipocyte differentiation-related protein and liver fatty acid binding protein, and increased the mRNA of ILK, whereas the mRNAs encoding integrin-beta1 and angiopoietin-like 4 were unchanged. Using immunohistochemistry, we determined that the intensity of PPAR-beta expression was stronger in rectal cancers with better differentiation than in those with poor differentiation, and was stronger in early-stage tumors than in advanced ones. Together, these findings consistently indicate that PPAR-beta may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer, having a role as an inhibitor in the carcinogenesis and progression of colorectal cancer. Interestingly, PPAR-beta seems to have a more important role in poorly metastatic cells than in highly metastatic ones. [PUBLICATION ABSTRACT]</description><subject>Cell adhesion &amp; migration</subject><subject>Cellular biology</subject><subject>Colorectal cancer</subject><subject>Fatty acids</subject><subject>Gene expression</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNjk1OxDAMhSMEEuVnxwEi9i1u2lKyRiAktuwQGmUSV5Mh2CVJgaNwXFLEAVjZ8vv83hPiooWmhe7misk2CkA33QgHomr78boeBt0figr0ALVWnToWJyntAWDUoCrx_UhsXx1_kuRJzhj5yyd-QzlHDn7CaDLH2tjsP0xGJyNanNfT8xazeZGe3GIxyYApSeen8oGUvcmeSRpyEmlnaCUshlBPfhuZsNgV1e0wrVgJthzKYlcy_pLpTBxNJiQ8_5un4vL-7un2oS7F3hdMebPnJVKRNkqNXa_7fuz-Bf0AHX1g9A</recordid><startdate>20100128</startdate><enddate>20100128</enddate><creator>Yang, L</creator><creator>Olsson, B</creator><creator>Pfeifer, D</creator><creator>Jönsson, J -i</creator><creator>Zhou, Z -g</creator><creator>Jiang, X</creator><creator>Fredriksson, B -a</creator><creator>Zhang, H</creator><creator>Sun, X -f</creator><general>Nature Publishing Group</general><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20100128</creationdate><title>Knockdown of peroxisome proliferator-activated receptor-[beta] induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells</title><author>Yang, L ; Olsson, B ; Pfeifer, D ; Jönsson, J -i ; Zhou, Z -g ; Jiang, X ; Fredriksson, B -a ; Zhang, H ; Sun, X -f</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2273494473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Cell adhesion &amp; migration</topic><topic>Cellular biology</topic><topic>Colorectal cancer</topic><topic>Fatty acids</topic><topic>Gene expression</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, L</creatorcontrib><creatorcontrib>Olsson, B</creatorcontrib><creatorcontrib>Pfeifer, D</creatorcontrib><creatorcontrib>Jönsson, J -i</creatorcontrib><creatorcontrib>Zhou, Z -g</creatorcontrib><creatorcontrib>Jiang, X</creatorcontrib><creatorcontrib>Fredriksson, B -a</creatorcontrib><creatorcontrib>Zhang, H</creatorcontrib><creatorcontrib>Sun, X -f</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, L</au><au>Olsson, B</au><au>Pfeifer, D</au><au>Jönsson, J -i</au><au>Zhou, Z -g</au><au>Jiang, X</au><au>Fredriksson, B -a</au><au>Zhang, H</au><au>Sun, X -f</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Knockdown of peroxisome proliferator-activated receptor-[beta] induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells</atitle><jtitle>Oncogene</jtitle><date>2010-01-28</date><risdate>2010</risdate><volume>29</volume><issue>4</issue><spage>516</spage><pages>516-</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><coden>ONCNES</coden><abstract>The role of peroxisome proliferator-activated receptor-beta/delta (PPAR-beta/delta) in the pathogenesis of colon cancer remains highly controversial. This study specifically silenced the PPAR-beta expression in three colon cancer cell lines with different metastatic potentials. Although PPAR-beta knockdown resulted in more malignant morphological changes, bigger colony sizes and lower carcinoembryonic antigen (CEA) secretion, and enhanced the cell-fibronectin adhesion, cell invasion and migration were unaffected. These effects were stronger in poorly metastatic cell lines compared with highly metastatic ones. Simultaneously, PPAR-beta knockdown decreased the mRNAs encoding adipocyte differentiation-related protein and liver fatty acid binding protein, and increased the mRNA of ILK, whereas the mRNAs encoding integrin-beta1 and angiopoietin-like 4 were unchanged. Using immunohistochemistry, we determined that the intensity of PPAR-beta expression was stronger in rectal cancers with better differentiation than in those with poor differentiation, and was stronger in early-stage tumors than in advanced ones. Together, these findings consistently indicate that PPAR-beta may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer, having a role as an inhibitor in the carcinogenesis and progression of colorectal cancer. Interestingly, PPAR-beta seems to have a more important role in poorly metastatic cells than in highly metastatic ones. [PUBLICATION ABSTRACT]</abstract><cop>New York</cop><pub>Nature Publishing Group</pub><doi>10.1038/onc.2009.370</doi></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2010-01, Vol.29 (4), p.516
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_journals_227349447
source Nature; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings
subjects Cell adhesion & migration
Cellular biology
Colorectal cancer
Fatty acids
Gene expression
title Knockdown of peroxisome proliferator-activated receptor-[beta] induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A22%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Knockdown%20of%20peroxisome%20proliferator-activated%20receptor-%5Bbeta%5D%20induces%20less%20differentiation%20and%20enhances%20cell-fibronectin%20adhesion%20of%20colon%20cancer%20cells&rft.jtitle=Oncogene&rft.au=Yang,%20L&rft.date=2010-01-28&rft.volume=29&rft.issue=4&rft.spage=516&rft.pages=516-&rft.issn=0950-9232&rft.eissn=1476-5594&rft.coden=ONCNES&rft_id=info:doi/10.1038/onc.2009.370&rft_dat=%3Cproquest%3E1949137291%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227349447&rft_id=info:pmid/&rfr_iscdi=true